Skip to main content

Table 2 Comprehensive synthesis of the systematic review findings

From: Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease

  1. References: Martínez-Torteya et al, 2015 [94], Ficiarà et al. 2021 [95], Jääskeläinen et al., 2020 [96], Olazarán et al., 2015 [97], Gray et al., 2013 [98],  Zhao et al., 2020 [99], Redolfi et al., 2020 [90], Wang et al., 2018 [100], Miller et al., 2020 [101], Hu et al., 2016 [102], Sh et al., 2021 [91],  Yilmaz et al., 2020 [103], Peña-Bautista et al., 2019 [104], Dong et al., 2021 [105], Chang et al., 2021 [106], Santangelo et al., 2020 [107],  Abate et al., 2021 [108], Lin et al., 2021 [109], Devanarayan et al., 2019 [110], Barbará-Morales et al., 2020 [93],  Iddi et al., 20119 [111], Lin et al., 2020 [112], Mathotaarachchi et al., 2017 [113], Khatri et al., 2020 [92], Gupta et al., 2019 [114], Zhang et al., 2012 [115], Eke et al., 2021 [116], Cheng et al., 2015 [117], Escudero et al., 2013 [118]